Company Overview and News

1
New team leaders for Singhi Advisors

2018-01-18 thehindubusinessline
Singhi Advisors, a Mumbai-based mid-market-focussed investment bank, has expanded its leadership team by appointing Ashok Panjwani as partner and Gaurav Agarwal as director. Panjwani was previously Managing Director of Wadia Group company The Bombay Burmah Trading Corp, and prior to that with Vendata Group as Director.
Upvote Downvote

 
Bombay Burmah reverses recent rally on profit booking

2017-10-19 indiainfoline
Bombay Burmah Trading Corporation lost 2.57% to Rs 1,682 on BSE on profit booking after gaining 25.82% in the preceding five trading sessions to settle at Rs 1,726.35 yesterday, 18 October 2017, from its close of Rs 1,372.10 on 11 October 2017.
Upvote Downvote

 
Investors flock to Bombay Burmah stock to get a taste of Britannia Ind...

2017-10-17 thehindubusinessline
The stock of Bombay Burmah Trading Corporation has gained 31 per cent in the last one month and more than doubled in the last one year. Buying interest in the stock comes as Britannia Industries’ valuation has soared to 43 times FY19 estimated earnings and looks a little stretched amid dull overall market sentiments (which will continue for a while). While Britannia Industries’ stock price hit a new lifetime high on October 13, the stock of Bombay Burmah achieved the same milestone again on Tuesday.
Upvote Downvote

 
NBCC (India) leads gainers on BSEs A group

2017-10-12 indiainfoline
Bombay Burmah Trading Corporation, Intellect Design Arena, TI Financial Holdings and Sundram Fasteners are among the other gainers in the BSEs A group today, 12 October 2017.
Upvote Downvote

 
Bombay Burmah Trading Corporation redeems CP worth Rs 50 cr

2017-09-21 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.
Upvote Downvote

 
Bombay Burmah Trading Corporation issues CP worth Rs 50 crore

2017-09-21 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.
Upvote Downvote

 
70 companies with pre-1947 roots

2017-08-16 livemint
American inventor Elisha Graves Otis built the first safety elevator in 1952. In the 1870s, Otis entered Europe. Its elevators were installed at the Kremlin, Balmoral Castle, the Hungarian Royal Palace and the Eiffel Tower. In the early 1900s, the Buckingham and the Mysore Palaces were also home to Otis elevators
Upvote Downvote

1
Nusli Neville Wadia buys 7 lakh shares of Bombay Burmah

2017-06-15 moneycontrol
On June 14, 2017 Archway Investment Company sold 11,80,690 shares of Bombay Burmah Trading Corporation at Rs 877 on the BSE.
Upvote Downvote

 
Bombay Burmah soars 6% post block deals

2017-06-14 indiainfoline
Bombay Burmah Trading Corporation surged nearly 6% in Wednesday’s morning session after almost 12 lakh shares traded in a block deal on the BSE.
Upvote Downvote

 
Bombay Burmah Trading Corporation allots NCDs aggregating Rs 150 crore

2017-05-23 indiainfoline
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.
Upvote Downvote

 
UPASI aims to enhance visibility of award-winning teas

2017-05-11 thehindubusinessline
The United Planters Association of South India (UPASI) intends to enhance the visibility of TGLIA (The Golden Leaf India Awards) teas through roadshows, food festivals and logo promotion in a big way.
Upvote Downvote

 
ICICI Bank in focus after announcing Q3 result

2017-05-04 indiainfoline
ICICI Banks net profit jumped 188.5% to Rs 2024.64 crore on 10.8% decline in total income to Rs 16585.76 crore in Q4 March 2017 over Q4 March 2016. The result was announced after market hours yesterday, 3 May 2017.
Upvote Downvote

 
Bombay Burmah Trading buys 4.92 crore shares of Bombay Dyeing

2017-03-21 moneycontrol
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
Upvote Downvote

 
Sensex, Nifty close lower on profit booking; Infosys drags

2017-03-07 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:
Upvote Downvote

 
Live Market Updates: Market trims morning losses, Nifty around 8950; Hindalco down 3%

2017-03-07 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...